New search Hide text from Guidelines
N NERVOUS SYSTEMN03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
This group comprises preparations used in the treatment of epilepsy.
Combined preparations are classified at separate 5th levels using the corresponding 50-series.
The group is subdivided according to chemical structure.
The DDDs for the antiepileptics are based on combination therapy. |
N03AA Barbiturates and derivatives
Barbiturates used mainly as hypnotics/sedatives are classified in N05C - Hypnotics and sedatives.
Phenobarbital, which is used both as an antiepileptic and as a sedative, is classified in this group.
Combinations with phenytoin are classified in N03AB.
N03AB Hydantoin derivatives
Combinations of phenytoin and barbiturates are classified in this group.
N03AC Oxazolidine derivatives
N03AD Succinimide derivatives
N03AE Benzodiazepine derivatives
Clonazepam is classified in this group.
All other benzodiazepines are classified as anxiolytics in N05B (e.g. diazepam) or hypnotics/sedatives in N05C (e.g. midazolam).
N03AF Carboxamide derivatives
N03AG Fatty acid derivatives
N03AX Other antiepileptics
This group comprises antiepileptics, which cannot be classified in the preceding groups.
Fenfluramine indicated for the treatment of seizures associated with Dravet syndrome is classified here.
Gabapentin and pregabalin are classified in N02BF Gabapentinoids.
The DDDs for stiripentol and fenfluramine are based on the treatment of children with a bodyweight of 20 kg. |
Last updated: 2024-01-26